Lazard Asset Management
BEAM icon

Lazard Asset Management’s Beam Therapeutics BEAM Stock Holding History

Lazard Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24
Closed – – 2311
2024
Q4 		$0 Sell
24
-54,551
-100% -$1.39M ﹤0.01% 2290
2024
Q3 		$1.34M Buy
54,575
+7,659
+16% +$198K ﹤0.01% 990
2024
Q2 		$1.1M Sell
46,916
-8,177
-15% -$201K ﹤0.01% 956
2024
Q1 		$1.82M Sell
55,093
-3,413
-6% -$106K ﹤0.01% 840
2023
Q4 		$1.59M Sell
58,506
-2,284
-4% -$56.7K ﹤0.01% 889
2023
Q3 		$1.46M Sell
60,790
-1,700
-3% -$45.6K ﹤0.01% 911
2023
Q2 		$2M Sell
62,490
-15
-0% -$487 ﹤0.01% 889
2023
Q1 		$1.91M Buy
62,505
+816
+1% +$32.2K ﹤0.01% 917
2022
Q4 		$2.41M Sell
61,689
-52,163
-46% -$2.34M ﹤0.01% 880
2022
Q3 		$5.42M Buy
113,852
+5,820
+5% +$332K 0.01% 690
2022
Q2 		$4.18M Buy
108,032
+37,182
+52% +$1.48M 0.01% 767
2022
Q1 		$4.06M Buy
70,850
+17,722
+33% +$1.16M ﹤0.01% 789
2021
Q4 		$4.23M Buy
53,128
+27,322
+106% +$2.34M ﹤0.01% 803
2021
Q3 		$2.25M Buy
25,806
+1,215
+5% +$122K ﹤0.01% 896
2021
Q2 		$3.17M Buy
24,591
+24,210
+6,354% +$1.93M ﹤0.01% 792
2021
Q1 		$30K Buy
+381
New +$36.2K ﹤0.01% 1642

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lazard Asset Management's BEAM Position: Q1 2025 in Review

Lazard Asset Management sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 24 shares.

Lazard Asset Management first reported a position in BEAM in Q1 2021 and held it in 16 quarters. The position peaked at $5.42M in Q3 2022. 238 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

  • Lazard Asset Management reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 24 Beam Therapeutics shares in Q1 2025.
  • Lazard Asset Management first reported a position in Beam Therapeutics in Q1 2021 and held it in 16 quarters.
  • Lazard Asset Management's Beam Therapeutics position peaked at $5.42M in Q3 2022.
  • 238 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.